Home › Mesothelioma › Texas › Houston
Mesothelioma clinical trials in Houston, TX
16 studies for Mesothelioma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- The University of Texas MD Anderson Cancer Center (site 127), Houston
SW-682 in Advanced Solid Tumors
RecruitingPhase 1
- U.T. MD Anderson Cancer Center, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
RecruitingPhase 1/2Healthy volunteers welcome
- Baylor St Lukes, Houston
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- MD Anderson, Houston
- NEXT Oncology Houston, Houston
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
RecruitingPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RecruitingPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RecruitingPhase 1
- MDACC, Houston
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
A Study of VET3-TGI in Patients With Solid Tumors
RecruitingPhase 1
- University of Texas MD Anderson Cancer Center, Houston
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
About Mesothelioma
Mesothelioma is a tumor of mesothelium, a tissue that lines lungs and other organs. Most people who get it have inhaled asbestos. Read the symptoms.
More about Mesothelioma on MedlinePlus
Mesothelioma trials in other cities
- New York City, NY11 studies
- Washington, DC9 studies
- Boston, MA9 studies
- Los Angeles, CA8 studies
- Nashville, TN8 studies
- Chicago, IL8 studies
- Arlington, VA6 studies
- Pittsburgh, PA6 studies
- Dallas, TX5 studies
- Edison, NJ5 studies
- Rochester, MN5 studies
- Seattle, WA5 studies
Other studies in Houston
- Non-Small Cell Lung Cancer143 studies
- Breast Cancer126 studies
- Cancer (all types)124 studies
- Colorectal Cancer101 studies
- Metastatic Cancer100 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia88 studies
- Lung Cancer78 studies
- Prostate Cancer73 studies
- Endometrial Cancer69 studies
- Melanoma61 studies
- Pancreatic Cancer59 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.